Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

Lemin Zheng(Peking University), Stanley L. Hazen(Cleveland Clinic)
Journal of Clinical Investigation
August 16, 2004
Cited by 647


Related Papers